T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Western Alliance Bancorporation
WAL
$9.77B
| $411M | 0.05% |
5,348,916
-619,610
| -10% | -$47.6M |
|
302
Lattice Semiconductor
LSCC
$8.82B
| $409M | 0.05% |
7,800,552
+1,517,395
| +24% | +$79.6M |
|
303
Automatic Data Processing
ADP
$119B
| $405M | 0.05% |
1,325,371
-64,029
| -5% | -$19.6M |
|
304
Globant
GLOB
$2.47B
| $400M | 0.05% |
3,400,397
-1,034,257
| -23% | -$122M |
|
305
Alkermes
ALKS
$4.45B
| $389M | 0.05% |
11,788,245
-468,202
| -4% | -$15.5M |
|
306
Trane Technologies
TT
$89.2B
| $387M | 0.05% |
1,149,462
-109,018
| -9% | -$36.7M |
|
307
Hubbell
HUBB
$23.2B
| $387M | 0.05% |
1,169,393
-403,488
| -26% | -$134M |
|
308
Voya Financial
VOYA
$7.44B
| $385M | 0.05% |
5,679,580
+1,095,190
| +24% | +$74.2M |
|
309
RTX Corp
RTX
$209B
| $381M | 0.05% |
2,877,164
-13,290
| -0.5% | -$1.76M |
|
310
Loews
L
$20.3B
| $381M | 0.05% |
4,140,631
-490,946
| -11% | -$45.1M |
|
311
KKR & Co
KKR
$128B
| $380M | 0.05% |
3,286,420
+220,230
| +7% | +$25.5M |
|
312
Popular Inc
BPOP
$8.34B
| $378M | 0.05% |
4,094,495
-98,274
| -2% | -$9.08M |
|
313
Wingstop
WING
$7.43B
| $372M | 0.05% |
1,646,934
+496,717
| +43% | +$112M |
|
314
Novo Nordisk
NVO
$244B
| $370M | 0.05% |
5,324,666
-1,020,452
| -16% | -$70.9M |
|
315
Duolingo
DUOL
$14.1B
| $370M | 0.05% |
1,190,382
-149,398
| -11% | -$46.4M |
|
316
RPM International
RPM
$16.2B
| $362M | 0.04% |
3,132,455
+128,587
| +4% | +$14.9M |
|
317
Crown Castle
CCI
$41.5B
| $358M | 0.04% |
3,433,109
+2,028,718
| +144% | +$211M |
|
318
IDEX
IEX
$12.1B
| $355M | 0.04% |
1,963,041
-1,703,736
| -46% | -$308M |
|
319
Bristol-Myers Squibb
BMY
$94B
| $353M | 0.04% |
5,789,376
-1,738,535
| -23% | -$106M |
|
320
Uber
UBER
$200B
| $352M | 0.04% |
4,835,707
-7,994,330
| -62% | -$582M |
|
321
Ascendis Pharma
ASND
$11.8B
| $352M | 0.04% |
2,256,102
-27,105
| -1% | -$4.22M |
|
322
Zebra Technologies
ZBRA
$15.9B
| $346M | 0.04% |
1,226,283
-70,129
| -5% | -$19.8M |
|
323
Caterpillar
CAT
$202B
| $342M | 0.04% |
1,038,105
+15,687
| +2% | +$5.17M |
|
324
Owens Corning
OC
$12.7B
| $340M | 0.04% |
2,380,123
+957,295
| +67% | +$137M |
|
325
Avidity Biosciences
RNA
$5.76B
| $335M | 0.04% |
11,338,098
+295,275
| +3% | +$8.72M |
|